Lamber Eaton myasthenic Syndrome Flashcards
Which condition is Lambert Eaton Myasthenic Syndrome associated with
Small cell lung cancer
Pathophysiology of Lambert Eaton Myasthenic syndrome
Antibodies produced against the voltage gated calcium channels in the presynaptic terminals of the neuromuscular junction
Features of Lambert Eaton Myasthenic syndrome
Slowly progressive muscle weakness
Affects the proximal muscles - notably proximal leg weakness
Presentation of Lambert Eaton Myasthenic syndrome
Proximal muscle weakness
Diplopia - affecting intraocular muscles
Slurred speech - affecting the oropharyngeal muscles
Ptosis - affecting the levator muscles
Autonomic dysfunction:
Dry mouth
Blurred vision
Impotence
Hyporeflexia
Post tetanic potentiation
Dizziness
Post tetanic potentiation
Reflexes become temporarily normal for a short period of time following a period of strong muscle contraction
Treatment of Lambert Eaton Myasthenic Syndrome
Amifampridine - allows more acetylcholine to be released in the neuromuscular junction space by blocking voltage gated potassium channels in the presynaptic cell, prolonging depolarisation
Immunosuppression - Prednisolone or azathioprine
IV immunoglobulins
Plasmapheresis
Investigations for Lambert Eaton Myasthenic syndrome
Investigate for SCLC
- CXR
- lung biopsy
Antibody test